Medcolcanna Organics Inc. Is Granted THC Psychoactive Quota to Be Used in Magistral Formulations and Other Medicinal Applications Medcolcanna", " MCCN" or the " Company"), a Canadian integrated medical cannabis company with operations in Colombia, is pleased to announce it has been granted a Psychoactive Quota for the production of THC Derivates by the Ministry of Health and Social Protection in Colombia. This comes as the result of Medcolcanna's ability to meet regulatory requirements and the Company's commitment to provide access to cannabis based medication to patients in Colombia. Following the November 2020 INVIMA certification of MCCN's laboratory under its Good Elaboration Practices for Magistral Preparations with Cannabis (GEP) program, authorizing the Company to manufacture high- and low-THC magistral preparations domestically, the grant of this latest THC Quota positions the Company as one of the few cannabis companies in the country with a certified lab for finished medicinal products.